<DOC>
	<DOCNO>NCT01527344</DOCNO>
	<brief_summary>Cardiac allograft vasculopathy ( CAV ) progressive disease coronary artery transplant heart significant cause morbidity mortality . The broad objective research study advance ability diagnose early possible presence CAV non-invasively predict patient increase risk CAV novel technique . Optical coherence tomography ( OCT ) novel intracoronary imaging technique use optical analog ultrasound resolution 10 time great resolution intravascular ultrasound ( IVUS ) . Endothelial progenitor cell ( EPCs ) peripheral blood show play role pathogenesis atherosclerosis peripheral arterial tonometry clinical tool use predict endothelial dysfunction ( precursor atherosclerosis ) validate non-transplant patient . Patients scheduled routine cardiac catheterization IVUS Mayo Clinic Rochester , Minnesota ( MN ) reach inclusion exclusion criterion study approach day get inform consent perform OCT , blood sample peripheral endothelial function test . The investigator aim 1 ) compare frequency plaque type CAV define OCT versus IVUS-Virtual Histology ( IVUS-VH ) , 2 ) predict presence severity CAV absolute count EPCs 3 ) peripheral endothelial function score .</brief_summary>
	<brief_title>Assessment Cardiac Allograft Vasculopathy With Optical Coherence Tomography</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>patient age 18 old patient cardiac transplant undergo routine CAV surveillance patient &lt; 18 year old patient acute rejection patient active infection patient chronic renal insufficiency glomerular filtration rate ( GFR ) &lt; 30ml/min patient able give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>OCT</keyword>
	<keyword>IVUS</keyword>
	<keyword>CAV</keyword>
</DOC>